Imaging of Renal Cancer



The incidence of adult renal cancer continues to increase, with little change in the predominant cell type, renal cell carcinoma. The rise in incidence is in part due to an increasing number of imaging studies performed for a variety of reasons and therefore incidental diagnosis. This has favorable prognostic impact, since cancer may be detected at an earlier stage.

The various imaging modalities including ultrasound, CT, and MRI available for the detection, diagnosis, staging, and surveillance of adult renal cancer are discussed in this chapter.

Future directions of imaging, including antibody-directed PET imaging, and functional imaging evaluation are also considered.


Renal Cell Carcinoma Apparent Diffusion Coefficient Renal Tumor Renal Mass Renal Cell Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7(5):245–57.PubMedCrossRefGoogle Scholar
  2. 2.
    Cho E, Adami HO, Lindblad P. Epidemiology of renal cell cancer. Hematol Oncol Clin North Am. 2011; 25(4):651–65.PubMedCrossRefGoogle Scholar
  3. 3.
    Sun M, Thuret R, Abdollah F, Lughezzani G, Schmitges J, Tian Z, Shariat SF, Montorsi F, Patard JJ, Perrotte P, Karakiewicz PI. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol. 2011;59(1):135–41.PubMedCrossRefGoogle Scholar
  4. 4.
    Agarwal R, Bergey M, Sonnad S, Butowsky H, Bhargavan M, Bleshman MH. Inpatient CT and MRI utilization: trends in the academic hospital setting. J Am Coll Radiol. 2010;7(12):949–55.PubMedCrossRefGoogle Scholar
  5. 5.
    Levin DC, Rao VM, Parker L, Frangos AJ, Sunshine JH. Recent trends in utilization rates of abdominal imaging: the relative roles of radiologists and nonradiologist physicians. J Am Coll Radiol. 2008;5(6): 744–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Decastro GJ, McKiernan JM. Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol Clin North Am. 2008;35(4):581–92. vi.PubMedCrossRefGoogle Scholar
  7. 7.
    Meister M, Choyke P, Anderson C, Patel U. Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease. Clin Radiol. 2009;64(6):589–600.PubMedCrossRefGoogle Scholar
  8. 8.
    Klatte T, Marberger M. High-intensity focused ultrasound for the treatment of renal masses: current status and future potential. Curr Opin Urol. 2009;19(2): 188–91.PubMedCrossRefGoogle Scholar
  9. 9.
    Pirasteh A, Snyder L, Boncher N, Passalacqua M, Rosenblum D, Prologo JD. Cryoablation vs. radiofrequency ablation for small renal masses. Acad Radiol. 2011;18(1):97–100.PubMedCrossRefGoogle Scholar
  10. 10.
    Venkatesan AM, Wood BJ, Gervais DA. Percutaneous ablation in the kidney. Radiology. 2011;261(2): 375–91.PubMedCrossRefGoogle Scholar
  11. 11.
    O’Connor OJ, McSweeney SE, Maher MM. Imaging of hematuria. Radiol Clin North Am. 2008;46(1):113–32. vii.PubMedCrossRefGoogle Scholar
  12. 12.
    Bai X, Wu CL. Renal cell carcinoma and mimics: pathologic primer for radiologists. AJR Am J Roentgenol. 2012;198(6):1289–93.PubMedCrossRefGoogle Scholar
  13. 13.
    Mucksavage P, Ramchandani P, Malkowicz SB, Guzzo TJ. Is ultrasound imaging inferior to computed tomography or magnetic resonance imaging in evaluating renal mass size? Urology. 2012;79(1):28–31.PubMedCrossRefGoogle Scholar
  14. 14.
    Gerst S, Hann LE, Li D, Gonen M, Tickoo S, Sohn MJ, Russo P. Evaluation of renal masses with contrast-enhanced ultrasound: initial experience. AJR Am J Roentgenol. 2011;197(4):897–906.PubMedCrossRefGoogle Scholar
  15. 15.
    Warshauer DM, McCarthy SM, Street L, Bookbinder MJ, Glickman MG, Richter J, Hammers L, Taylor C, Rosenfield AT. Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT. Radiology. 1988;169(2):363–5.PubMedGoogle Scholar
  16. 16.
    Pahernik S, Ziegler S, Roos F, Melchior SW, Thüroff JW. Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol. 2007;178(2):414–7. discussion 416–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Guðmundsson E, Hellborg H, Lundstam S, Erikson S, Ljungberg B. Swedish kidney cancer quality register group. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish kidney cancer quality register data. Eur Urol. 2011;60(5):975–82.PubMedCrossRefGoogle Scholar
  18. 18.
    Marberger M, Schatzl G, Cranston D, Kennedy JE. Extracorporeal ablation of renal tumours with high-intensity focused ultrasound. BJU Int. 2005; 95(2):52–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Tada S, Yamagishi J, Kobayashi H, Hata Y, Kobari T. The incidence of simple renal cyst by computed tomography. Clin Radiol. 1983;34(4):437–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Israel GM, Silverman SG. The incidental renal mass. Radiol Clin North Am. 2011;49(2):369–83.PubMedCrossRefGoogle Scholar
  21. 21.
    Silverman SG, Israel GM, Herts BR, Richie JP. Management of the incidental renal mass. Radiology. 2008;249(1):16–31.PubMedCrossRefGoogle Scholar
  22. 22.
    Catalano C, Fraioli F, Laghi A, Napoli A, Pediconi F, Danti M, Nardis P, Passariello R. High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma. AJR Am J Roentgenol. 2003;180(5):1271–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Flocks RH, Kadesky MC. Malignant neoplasms of the kidney; an analysis of 353 patients followed five years or more. J Urol. 1958;79(2):196–201.PubMedGoogle Scholar
  24. 24.
    Robson CJ. Radical nephrectomy for renal cell carcinoma. J Urol. 1963;89:37–42.PubMedGoogle Scholar
  25. 25.
    Hartman DS, Choyke PL, Hartman MS. From the RSNA refresher courses: a practical approach to the cystic renal mass. Radiographics. 2004;24(Suppl 1):S101–15.PubMedCrossRefGoogle Scholar
  26. 26.
    Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology. 1991;179(2):307–17.PubMedGoogle Scholar
  27. 27.
    Bosniak MA. The current radiological approach to renal cysts. Radiology. 1986;158(1):1–10.PubMedGoogle Scholar
  28. 28.
    Bosniak MA. The Bosniak renal cyst classification: 25 years later. Radiology. 2012;262(3):781–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Kim JK, Kim TK, Ahn HJ, Kim CS, Kim KR, Cho KS. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol. 2002;178(6):1499–506.PubMedCrossRefGoogle Scholar
  30. 30.
    Herts BR, Coll DM, Novick AC, Obuchowski N, Linnell G, Wirth SL, Baker ME. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol. 2002;178(2):367–72.PubMedCrossRefGoogle Scholar
  31. 31.
    Roudsari B, Moore DS, Jarvik JG. Trend in the utilization of CT for adolescents admitted to an adult level I trauma center. J Am Coll Radiol. 2010;7(10): 796–801.PubMedCrossRefGoogle Scholar
  32. 32.
    Lam JS, Leppert JT, Figlin RA, Belldegrun AS. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr Urol Rep. 2005;6(1): 7–18.PubMedCrossRefGoogle Scholar
  33. 33.
    Levy DA, Slaton JW, Swanson DA, Dinney CP. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol. 1998;159(4):1163–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med. 1996;335(12):865–75.PubMedCrossRefGoogle Scholar
  35. 35.
    Scatarige JC, Sheth S, Corl FM, Fishman EK. Patterns of recurrence in renal cell carcinoma: manifestations on helical CT. AJR Am J Roentgenol. 2001;177(3): 653–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Lam JS, Shvarts O, Pantuck AJ. Changing concepts in the surgical management of renal cell carcinoma. Eur Urol. 2004;45(6):692–705.PubMedCrossRefGoogle Scholar
  37. 37.
    Kawamoto S, Permpongkosol S, Bluemke DA, Fishman EK, Solomon SB. Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: role of CT and MR imaging. Radiographics. 2007;27(2):343–55.PubMedCrossRefGoogle Scholar
  38. 38.
    Davenport MS, Caoili EM, Cohan RH, Ellis JH, Higgins EJ, Willatt J, Fox GA. MRI and CT characteristics of successfully ablated renal masses: imaging surveillance after radiofrequency ablation. AJR Am J Roentgenol. 2009;192(6):1571–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Bostwick DG, Murphy GP. Diagnosis and prognosis of renal cell carcinoma: highlights from an international consensus workshop. Semin Urol Oncol. 1998;16(1):46–52.PubMedGoogle Scholar
  40. 40.
    Beck SD, Patel MI, Snyder ME, Kattan MW, Motzer RJ, Reuter VE, Russo P. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol. 2004;11(1):71–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Schuster TG, Ferguson MR, Baker DE, Schaldenbrand JD, Solomon MH. Papillary renal cell carcinoma containing fat without calcification mimicking angiomyolipoma on CT. AJR Am J Roentgenol. 2004;183(5):1402–4.PubMedCrossRefGoogle Scholar
  42. 42.
    Pedrosa I, Sun MR, Spencer M, Genega EM, Olumi AF, Dewolf WC, Rofsky NM. MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. Radiographics. 2008;28(4): 985–1003.PubMedCrossRefGoogle Scholar
  43. 43.
    Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS. MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol. 2010;195(6):W421–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Inci E, Hocaoglu E, Aydin S, Cimilli T. Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification. Eur J Radiol. 2012;81(5): 815–20.PubMedCrossRefGoogle Scholar
  45. 45.
    Sandrasegaran K, Sundaram CP, Ramaswamy R, Akisik FM, Rydberg MP, Lin C, Aisen AM. Usefulness of diffusion-weighted imaging in the evaluation of renal masses. AJR Am J Roentgenol. 2010;194(2): 438–45.PubMedCrossRefGoogle Scholar
  46. 46.
    Smaldone MC, Chen DY, Uzzo RG, Yu M. Molecular imaging of the small renal mass. Urol Oncol. 2011; 29(6):589–92.PubMedCrossRefGoogle Scholar
  47. 47.
    Kaur S, Venktaraman G, Jain M, Senapati S, Garg PK, Batra SK. Recent trends in antibody-based oncologic imaging. Cancer Lett. 2012;315(2):97–111.PubMedCrossRefGoogle Scholar
  48. 48.
    Israel GM, Bosniak MA. How I do it: evaluating renal masses. Radiology. 2005;236(2):441–50.PubMedCrossRefGoogle Scholar
  49. 49.
    Ng CS, Wood CG, Silverman PM, Tannir NM, Tamboli P, Sandler CM. Renal cell carcinoma: diagnosis, staging, and surveillance. AJR Am J Roentgenol. 2008;191(4):1220–32. doi: 10.2214/AJR.07.3568.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Lahey Clinic Medical CenterBurlingtonUSA

Personalised recommendations